Literature DB >> 25068012

Isotretinoin and ulcerative colitis: A case report and review of the literature.

Ioannis Papaconstantinou1, Anastasios Stefanopoulos1, Aspasia Papailia1, Christos Zeglinas1, Ioannis Georgopoulos1, Spyridon Michopoulos1.   

Abstract

This case report describes a case of ulcerative colitis the onset of which occurred after the use of isotretinoin for acne treatment. Our patient, a healthy male young adult, after several months of isotretinoin use, developed gastrointestinal disorders and after thorough medical workup was diagnosed with ulcerative colitis. The literature regarding a possible correlation between isotretinoin use and ulcerative colitis is scarce. Nevertheless, recent epidemiological studies have shed more light on this possible association.

Entities:  

Keywords:  Acne; Heroin addiction; Inflammatory bowel disease; Isotretinoin; Ulcerative colitis

Year:  2014        PMID: 25068012      PMCID: PMC4110532          DOI: 10.4240/wjgs.v6.i7.142

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  12 in total

1.  Isotretinoin and inflammatory bowel disease.

Authors:  Kendra Gail Bergstrom
Journal:  J Drugs Dermatol       Date:  2010-03       Impact factor: 2.114

2.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

3.  Inflammatory bowel disease: adverse effect of isotretinoin.

Authors:  Neofytos P Papageorgiou; Arie Altman; Yehuda Shoenfeld
Journal:  Isr Med Assoc J       Date:  2009-08       Impact factor: 0.892

4.  The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease.

Authors:  Cătălin Mihai Popescu; Michael Bigby
Journal:  JAMA Dermatol       Date:  2013-02       Impact factor: 10.282

5.  Inflammatory bowel disease and isotretinoin.

Authors:  M B Brodin
Journal:  J Am Acad Dermatol       Date:  1986-05       Impact factor: 11.527

6.  Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

Authors:  Raed O Alhusayen; David N Juurlink; Muhammad M Mamdani; Richard L Morrow; Neil H Shear; Colin R Dormuth
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551

7.  Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data.

Authors:  Mahyar Etminan; Steven T Bird; Joseph A Delaney; Brian Bressler; James M Brophy
Journal:  JAMA Dermatol       Date:  2013-02       Impact factor: 10.282

8.  Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.

Authors:  Charles N Bernstein; Zoann Nugent; Teresa Longobardi; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2009-07-21       Impact factor: 10.864

9.  Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study.

Authors:  T Gilat; D Hacohen; P Lilos; M J Langman
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

Review 10.  Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.

Authors:  J Rodrigo Mora
Journal:  Inflamm Bowel Dis       Date:  2008-02       Impact factor: 5.325

View more
  1 in total

1.  Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

Authors:  Xiaohong Wang; Dan Li; Yong Zhang; Shuang Wu; Fang Tang
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.